Zacks: Innophos Holdings, Inc. (IPHS) Receives Consensus Rating of “Hold” from Brokerages

Innophos Holdings, Inc. (NASDAQ:IPHS) has earned a consensus broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation.

Zacks has also given Innophos an industry rank of 223 out of 255 based on the ratings given to related companies.

A number of brokerages recently issued reports on IPHS. BidaskClub downgraded Innophos from a “buy” rating to a “hold” rating in a research report on Wednesday, July 25th. Zacks Investment Research downgraded Innophos from a “buy” rating to a “hold” rating in a research report on Thursday, July 5th. ValuEngine downgraded Innophos from a “hold” rating to a “sell” rating in a research report on Friday, October 12th. Finally, TheStreet downgraded Innophos from a “b-” rating to a “c+” rating in a research report on Thursday, August 23rd.

Shares of Innophos stock traded up $0.28 during trading hours on Friday, reaching $31.23. The company had a trading volume of 3,147 shares, compared to its average volume of 148,036. Innophos has a one year low of $27.46 and a one year high of $50.40. The company has a debt-to-equity ratio of 0.99, a current ratio of 2.75 and a quick ratio of 1.34. The firm has a market capitalization of $586.10 million, a P/E ratio of 13.03 and a beta of 0.70.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings results on Thursday, November 1st. The specialty chemicals company reported $0.58 EPS for the quarter, missing the Zacks’ consensus estimate of $0.59 by ($0.01). Innophos had a return on equity of 14.28% and a net margin of 2.21%. The company had revenue of $196.93 million during the quarter, compared to the consensus estimate of $197.20 million. During the same period in the previous year, the business earned $0.78 earnings per share. Innophos’s revenue was up 7.1% on a year-over-year basis. Sell-side analysts expect that Innophos will post 2.35 earnings per share for the current fiscal year.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IPHS. Investment Counselors of Maryland LLC raised its position in Innophos by 69.2% during the second quarter. Investment Counselors of Maryland LLC now owns 471,896 shares of the specialty chemicals company’s stock valued at $22,462,000 after purchasing an additional 193,003 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Innophos by 6.8% in the second quarter. BlackRock Inc. now owns 2,665,668 shares of the specialty chemicals company’s stock worth $126,885,000 after buying an additional 170,407 shares during the period. Northpointe Capital LLC increased its holdings in shares of Innophos by 2,069.0% in the third quarter. Northpointe Capital LLC now owns 169,140 shares of the specialty chemicals company’s stock worth $7,510,000 after buying an additional 161,342 shares during the period. Deprince Race & Zollo Inc. increased its holdings in shares of Innophos by 30.1% in the second quarter. Deprince Race & Zollo Inc. now owns 433,676 shares of the specialty chemicals company’s stock worth $20,643,000 after buying an additional 100,304 shares during the period. Finally, Wells Fargo & Company MN increased its holdings in shares of Innophos by 31.0% in the second quarter. Wells Fargo & Company MN now owns 238,344 shares of the specialty chemicals company’s stock worth $11,345,000 after buying an additional 56,464 shares during the period. Institutional investors and hedge funds own 93.92% of the company’s stock.

Innophos Company Profile

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Featured Article: Investing strategies using the yield curve

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply